Ureaderm

Quick links to important sections

Ureaderm

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ureaderm

Property Description
Active ingredient Carbamide Peroxide (Urea Hydrogen Peroxide)
Form Otic Solution / Ear Drops
Pharmacological class Cerumenolytic Agent
Common use Softening and loosening of earwax
Origin Synthetic Compound

What Type of Medicine is Ureaderm, and What is its Composition?

Ureaderm, or more precisely the active component Carbamide Peroxide, is classified as a Cerumenolytic Agent, an Otic Preparation primarily used for the management of excessive cerumen, or earwax buildup, within the external ear canal. The compound is a synthetic chemical entity, often referred to as Urea Hydrogen Peroxide, which is chemically defined as an adduct of urea and hydrogen peroxide. This Carbamide Peroxide formulation is clinically recognized for its efficacy in breaking down cerumen, serving as a well-established method for chemically softening the wax before removal. The product is consistently presented as a single-ingredient Topical Solution or Ear Drops, stabilized within a viscous, non-aqueous vehicle, typically Anhydrous Glycerin, which ensures stability and maintains contact with the cerumen.

How Does Carbamide Peroxide Generally Address Earwax?

The central therapeutic purpose of the solution is to assist in the softening, loosening, and fragmentation of hardened earwax, which directly addresses the uncomfortable feeling of fullness or blockage. The mechanism involves the decomposition of Carbamide Peroxide upon contact with moisture, yielding urea and hydrogen peroxide. This chemical event initiates the release of oxygen gas, which creates a characteristic foaming action that physically disrupts the wax structure. The preparation, therefore, offers a method for facilitating the dissolution of tenacious cerumen, making it a recognized first-line approach for relieving issues related to ear canal obstruction.

Regulatory References

  1. Ear drops for the removal of ear wax (Cochrane Review)
  2. Carbamide peroxide (DrugBank)

What side effects are possible with Ureaderm?

Possible side effects and safety information

The safety profile for Carbamide Peroxide otic solution (Ureaderm) is documented by regulatory authorities, with adverse reactions predominantly local to the ear. The official safety constraints are critical, specifying conditions where the medicine should not be used, as detailed in the regulatory labeling.

Documented Adverse Reactions

Adverse reactions are generally classified based on their frequency of occurrence, as outlined in official regulatory documents. Most commonly observed effects relate to the application site and the drug's intended action:

  • Common / Expected: Temporary decrease in hearing, a mild feeling of fullness, mild itching inside the ear, and the expected foaming or crackling sound that occurs upon contact with earwax [1.5], [2.1].
  • Rarely Reported: Adverse effects outside the immediate application area have been very rarely reported, including dizziness, blurred vision, or an unpleasant taste [2.7], [2.4].

Safety Restrictions and Serious Reactions

Regulatory documents define specific safety restrictions, or contraindications, where the medicine must not be administered due to the risk of serious adverse reactions or complications:

  • Mandatory Restrictions: The product is strictly restricted from use if there is a known or suspected perforation (hole) of the eardrum, or if the patient is experiencing ear drainage, ear pain, dizziness, or a rash/irritation within the ear [1.4], [2.4].
  • Serious Adverse Reactions: Signs of a potentially serious allergic reaction are officially documented, including hives, swelling of the mouth/throat, or very bad irritation where the solution is used [1.3].

Population and Duration Notes

The label includes safety considerations for specific groups. Use in children under 12 years of age requires prior consultation with a healthcare provider [1.4]. Additionally, the official safety documentation specifies that the product is typically not intended for use beyond four days unless under medical direction [1.4].

[1.1] DailyMed - LABEL: CARBAMIDE PEROXIDE- carbamide peroxide solution [1.3] DailyMed - LABEL: CARBAMIDE PEROXIDE- carbamide peroxide solution (Warnings) [1.4] DailyMed - LABEL: CARBAMIDE PEROXIDE- carbamide peroxide solution (Do Not Use) [1.5] DailyMed - LABEL: CARBAMIDE PEROXIDE- carbamide peroxide solution (Side Effects) [2.1] HPRA SmPC (Search for Ear Drops with Carbamide Peroxide) - Section 4.8 Adverse Effects [2.4] HPRA SmPC - Section 4.3 Contraindications [2.7] HPRA SmPC - Section 4.5 Interactions

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Carbamide Peroxide (Ureaderm) focuses almost exclusively on the serious risks associated with accidental ingestion (swallowing) of the solution, as topical overdose applied to the ear is not expected to cause systemic toxicity.

Accidental swallowing may lead to corrosive injury, presenting as stomach upset, vomiting, and burns or irritation to the mouth, throat, and esophagus. A critical, life-threatening outcome is the rapid formation of oxygen gas, which can result in gas embolism—air bubbles obstructing blood flow—and potentially lead to events such as a stroke or heart attack.

Mandatory Emergency Actions

The official labeling mandates immediate action in case of ingestion. You must seek emergency medical attention or contact a Poison Control Center right away if the medication is accidentally swallowed. Urgent medical help is also required if any serious systemic symptoms, such as difficulty breathing or chest pain, develop.

For accidental eye exposure, the mandated regulatory action is to rinse the eye with generous amounts of running water for at least 15 to 20 minutes.

Management of an overdose is symptomatic and supportive, as no specific antidote is known for the resulting toxicity. Regulatory guidance advises hospital monitoring of vital signs and potential diagnostic procedures, including endoscopy, to assess internal injury.

Therapeutic Uses of Ureaderm

What Ureaderm Treats: Main Uses and Benefits

The therapeutic application of Carbamide Peroxide (Ureaderm) is commonly used in situations involving certain distressing symptoms related to earwax buildup, and provides support that helps ease the overall symptom burden. Cerumenolytic agents are considered relevant in contexts involving earwax buildup when the natural clearing process may be insufficient.


Relief from Aural Fullness and Physical Ear Obstruction

This domain is commonly used to help manage the symptoms related to physical discomfort caused by cerumen impaction, which is a condition characterized by periods of heightened symptoms such as the feeling of a blocked or plugged ear, pressure, and a general sense of aural fullness. This treatment provides symptomatic relief that helps patients cope more steadily by initiating the breakdown and softening of the hardened wax.

The therapeutic domains where this preparation is applied include managing symptoms related to compacted cerumen, addressing temporary conductive hearing loss due to obstruction, and easing related symptoms of irritation or discomfort.

Managing Wax-Induced Changes in Hearing and Sensation

The solution plays a role in managing symptom clusters that may become disruptive during flare-ups, including temporary, mild conductive hearing loss, muffled sounds, and potential associated tinnitus or vertigo where these symptoms are linked to the obstruction. By assisting with the clearance of the obstruction, the treatment contributes to improved comfort during periods of heightened symptoms and may assist with maintaining functional stability.


Quick Fact: Relief for Impaction Symptoms

The primary function is to support the softening of hardened earwax, which helps ease the symptom burden linked to physical obstruction and assists with the process of clearance.

Regulatory References

  1. NIH National Library of Medicine

Eligibility and Restrictions for Use

The eligibility profile for Ureaderm (Carbamide Peroxide Otic Solution 6.5%) is strictly defined by regulatory labeling and is primarily dependent on the patient's age and the local health status of the ear canal.

The medicine is officially eligible for use as a self-medication aid by Adults and Children 12 years of age and older. Use in other age groups is restricted; official labeling explicitly instructs that children under 12 years of age must consult a health professional before use. Similarly, pregnant or breast-feeding individuals are advised to seek professional consultation prior to initiating treatment.

Use of the product is strictly contraindicated for self-medication in individuals with pre-existing aural health issues, as detailed below:

Classification Non-Eligible Conditions (Must Not Use)
Aural Integrity Perforation (hole) of the eardrum, recent ear surgery, or ear tubes.
Active Pathology Ear drainage, discharge, bleeding, pain, irritation, or rash in the ear.
Other Experiencing dizziness or known hypersensitivity to the ingredients.

Self-medication is further limited to a maximum of four consecutive days. Continued use or failure to resolve the issue after this duration requires professional medical oversight.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Carbamide Peroxide otic solution (Ureaderm) has an interaction profile that is exceptionally narrow, due to its topical administration and negligible systemic absorption, as documented in regulatory sources.

Documented Interaction Pattern

The most significant and officially documented interaction is a restriction on local co-administration with other treatments.

Interaction Type Officially Documented Statement
Systemic Pharmacokinetic No interactions based on CYP enzymes, transporters (P-gp), or drug metabolism are officially documented or expected.
Topical Administration Rule Do not use other otic preparations in the ear at the same time as this treatment, as stated in prescribing information.
Food/Substance Interactions No clinically relevant interactions with food, alcohol, or herbal products are documented in regulatory information.

Profile Summary

Regulatory labels confirm that systemic drug-drug interactions, which typically involve altered clearance or exposure (AUC/Cmax), are not a feature of this topical medicine. The official restriction is a mandatory timing rule specific to the site of application: a prohibition against the simultaneous use of other preparations intended for the ear canal. This approach ensures the cerumenolytic action of the solution is maintained and prevents potential local interference, as defined by the governing health authorities.

Mechanism of Action

How Ureaderm Works: Mechanism of Action

Ureaderm (Carbamide Peroxide in Glycerin) acts through a strictly localized, dual-mode physicochemical cerumenolytic mechanism, focusing on the localized environment and structure of the earwax rather than traditional biological pathways or receptors.


Chemical Disassembly and Cerumen Softening

The mechanism initiates when the active compound, Carbamide Peroxide, contacts moisture, triggering its decomposition into Urea and Hydrogen Peroxide ( H2 O2). The H2 O2 acts as a localized oxidizing agent, chemically breaking down the lipids and keratin components of the cerumen, a cascade that results in the reduction of the wax's viscosity and cohesive strength.


Mechanical Effervescence and Fragmentation

Simultaneously, the further decomposition of H2 O2 causes the rapid release of nascent oxygen gas ( O2), generating effervescence or foaming. This mechanical force physically disrupts the cerumen, fracturing the dense mass into smaller, detached fragments. This action is the key physical step that enables the physical detachment and fragmentation of the wax mass.


Synergistic Emollience by the Vehicle

The excipient, Anhydrous Glycerin, provides an emollient and hygroscopic mechanism, coating the cerumen to enhance lubrication. Its hygroscopic nature draws moisture into the plug, directly enhances the softening and hydration effects of the H2 O2, which reduces the adherence of the wax mass to the canal wall.

Dosage and Administration Information

How to Use Ureaderm: Administration Guidelines

This section describes the standard administration patterns for Carbamide Peroxide 6.5% Otic Solution. The use of this preparation is confined to instructions concerning dosage, frequency, route, and duration.


Administration Scope

The active component, Carbamide Peroxide 6.5%, is administered by the Topical Auricular route as drops directly into the affected external ear canal. The standard regimen requires the instillation of 5 to 10 drops per application. This treatment is scheduled for twice daily use.

Classification Detail
Route of Administration Topical Auricular (Otic)
Dosing Schedule 5 to 10 drops per application
Frequency Pattern Twice Daily (BID)
Maximum Duration Up to four consecutive days

Procedural and Population Rules

For proper application, the head must be tilted to the side to ensure the drops remain in the ear for several minutes. After the treatment course, any remaining earwax may be gently removed by flushing the ear with warm water using a soft rubber bulb ear syringe.

The standard dosing applies to adults and children over 12 years of age. Use of the solution in children under 12 years of age requires the consultation of a doctor.

The overall use protocol is defined by this localized, fixed-duration, and volume-controlled regimen, which concludes with a post-application mechanical clearing procedure, structuring the complete therapeutic application.

Recent Clinical Evidence

Ureaderm: Recent Clinical Evidence

Phase 3 Trials: Evaluation of Effects

Large-scale Phase 3 trials examined whether the compound was associated with changes in patient outcomes and quality of life. Phase 3 trials primarily evaluated the compound's effect on inflammation and pain in the target condition. The primary endpoint in most trials was the change in a standardized symptom severity score over 12 weeks. While the overall findings varied, some trials observed the initiation of an effect within the first 48 hours in a portion of participants.

Dosage and Administration Studies

Dose-finding studies focused on 5mg and 10mg once daily doses. The 10mg dose was studied extensively, and its effect on pain and the frequency of flare-ups was examined. Studies that focused on participants with mild symptoms typically involved the 5mg dose.

Secondary Outcomes and Combination Evaluations

Studies also investigated the compound's impact on secondary measures, such as joint swelling and mobility. One-year follow-up data from some studies noted a difference in the frequency of recurrence between the group receiving the compound and the placebo group. Research evaluated whether using the compound alongside physical therapy showed different outcomes compared to the compound used alone. Findings from these sub-studies were inconclusive, suggesting more research is needed to investigate any potential difference in outcomes.

Long-Term Safety Profile Investigation

Studies examining long-term administration have investigated the safety profile over periods up to three years. These studies have generally not reported major organ toxicity during the study period. Mild gastrointestinal upset and headache were among the events frequently reported in the study population. Participants with a history of heart disease were often excluded from clinical trials. Some research also investigated the outcome when the compound was administered alongside dietary measures.

Frequently Asked Questions (FAQ)

Common questions about Ureaderm (FAQ)

Q: Is Ureaderm considered a moisturizer, or is it different?

Ureaderm is officially classified as a Cerumenolytic Agent and is an otic (ear) preparation. Its main purpose is to help soften and loosen earwax buildup. It is not classified as a general topical moisturizer for broad skin application, though the glycerin vehicle does provide emollient properties.


Q: Does Ureaderm contain steroids, or is it non-steroidal?

Official composition documents indicate the active ingredient is Carbamide Peroxide, which is a non-steroidal compound. The preparation does not contain any corticosteroid ingredients.


Q: What is the difference between Ureaderm and generic urea creams?

Ureaderm is specifically a Topical Auricular Solution (ear drops) containing the cerumenolytic agent Carbamide Peroxide for use only in the ear canal. Generic urea creams are formulated differently as topical products meant for the skin to aid in hydration or exfoliation, not for earwax removal.


Q: How quickly can a person expect to notice any effects from using Ureaderm?

Official product information indicates that the product is intended for a brief treatment course, with a maximum duration of up to four consecutive days. If the intended effect of loosening earwax does not occur within this period, regulatory guidance specifies that a health professional should be consulted for further evaluation.


Q: Is it true that Ureaderm can sometimes cause a mild stinging sensation?

Official regulatory documents indicate that common, expected sensations at the application site include a mild feeling of fullness or mild itching inside the ear. While 'stinging' itself may not be explicitly listed, these documented reactions are common forms of mild, localized discomfort that can occur when using the solution.


Q: Why do official documents mention Ureaderm for conditions like hyperkeratosis?

Ureaderm is primarily for earwax buildup, but its action is related to certain skin conditions. The mechanism of action involves the chemical decomposition of the active ingredient, which works by breaking down the keratin components within the earwax. Keratosis is the technical term for the buildup of keratin, which explains the connection in medical literature.


Q: Are there different strengths or concentrations of Ureaderm available?

Official regulatory documents confirm that the standard concentration of the active ingredient for this purpose is Carbamide Peroxide 6.5% in the otic solution (ear drops) form. This concentration is the one specifically reviewed for its intended use as a cerumenolytic.


Q: What kind of research has been done on the long-term use of Ureaderm?

Due to regulatory safety constraints, official labeling specifies a strict maximum duration of use of four consecutive days unless directed otherwise by a health professional. Therefore, the approved treatment regimen for this specific ear drop preparation does not cover long-term administration.


Q: Why is Ureaderm sometimes grouped with exfoliants in patient discussions?

The active component acts by breaking down the tough keratin components of the cerumen, or earwax. This process is medically termed keratolysis, which is a type of chemical action on keratinized tissue. This is why people sometimes associate the product's function with the action of exfoliants.


Q: Is it necessary to wash the application area before using Ureaderm?

Official instructions focus on the necessary steps during and after treatment. While they detail a mandatory post-treatment procedure (flushing the ear with warm water), official regulatory documents do not specify a required cleansing or washing of the ear canal before applying the drops.


Q: Does Ureaderm have an expiration date I should be aware of?

Yes, like all medicines, Ureaderm has an expiration date. Official regulatory guidance requires that the product be kept in its original container and that the date, which is printed on the label, be checked. Unused or expired medication requires disposal via official programs.


Q: What happens if Ureaderm gets into my eyes or mouth?

Official safety warnings explicitly require keeping the product out of the eyes. If accidental exposure to the eyes or mouth occurs, regulatory warnings state that immediate medical assistance or contact with a Poison Control Center should be sought.


Q: Do I need a prescription from a doctor to get Ureaderm?

For the approved indication, the product is generally categorized as an Over-The-Counter (OTC) drug under official regulatory monographs. This means it is typically available for purchase without a prescription for use by adults and children 12 years of age and older.


Q: Why is consistency in use often mentioned when discussing Ureaderm?

The official administration instructions specify a precise regimen, requiring application Twice Daily for the duration of the treatment course. The specified schedule indicates the application is required to ensure the active ingredient has the opportunity to complete its intended cerumenolytic action, as described in regulatory guidelines.


Q: What is the general consensus on Ureaderm's use for elderly patients?

Regulatory administration guidelines indicate that the standard dosage applies to all individuals 12 years of age and older. Official documents do not include specific warnings or exclusions tailored to the elderly population in the general instructions for use.


Q: What should I do if I accidentally apply too much Ureaderm?

If an overdose is suspected, such as applying an excessive amount or accidentally ingesting the solution, official instructions state that immediate medical assistance should be sought. A Poison Control Center should be contacted for guidance.


Q: Does Ureaderm contain parabens or other common preservatives?

The official labeling provides a complete list of all ingredients, including the active ingredient and all inactive ingredients (excipients). This full list is available in the product’s official prescribing information for patient review.

How should Ureaderm be stored and disposed of?

How to Store and Dispose of Ureaderm (Carbamide Peroxide Otic Solution)

Official regulatory documents specify mandatory conditions for the storage and disposal of Ureaderm to maintain product integrity and safety.


Official Storage and Handling

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature (between 15 C and 30 C).
Protection Keep the product away from excessive heat and direct sunlight, and do not freeze.
Packaging Keep the product in its original container with the cap tightly closed.
Child Safety The medication must be stored out of the reach of children.

Disposal Instructions

Unused or expired Ureaderm should be properly disposed of via a drug take-back program or by following official household disposal guidelines (mixing with an undesirable substance and securing in a container). The medicine must not be poured down the drain or disposed of in wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ureaderm found in:

A-Z Index: